We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$31M
AUM Growth
-$1.67M
(-5.1%)
Cap. Flow
-$2.64M
Cap. Flow
% of AUM
-8.53%
Top 10 Holdings %
Top 10 Hldgs %
64.27%
Holding
50
New
–
Increased
3
Reduced
29
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$308K |
| 2 |
AMRS
Amyris Inc.
AMRS
|
+$107K |
| 3 |
Philip Morris
PM
|
+$14.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NTRP
Neurotrope, Inc. Common
NTRP
|
+$1.52M |
| 2 |
NexGen Energy
NXE
|
+$406K |
| 3 |
Qualcomm
QCOM
|
+$298K |
| 4 |
Apple
AAPL
|
+$151K |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$130K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.81% |
| 2 | Healthcare | 17.59% |
| 3 | Materials | 15.45% |
| 4 | Industrials | 7.98% |
| 5 | Financials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRS
1
DELISTED
Amyris Inc.
AMRS
| $4.79M | 15.45% |
1,139,531
+28,592
| +3% | +$107K |
|
|
2
Apple
AAPL
$4.89T
| $3.75M | 12.11% |
67,000
-2,880
| -4% | -$151K |
|
|
3
Ionis Pharmaceuticals
IONS
$9.35B
| $1.84M | 5.93% |
30,677
-1,993
| -6% | -$130K |
|
4
Aflac
AFL
$63.9B
| $1.58M | 5.12% |
30,301
-1,034
| -3% | -$54.6K |
|
|
5
Qualcomm
QCOM
$176B
| $1.58M | 5.11% |
20,740
-3,963
| -16% | -$298K |
|
|
CPRX
6
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.5M | 4.86% |
283,334
+57,750
| +26% | +$308K |
|
|
RTEC
7
DELISTED
Rudolph Technologies Inc
RTEC
| $1.45M | 4.67% |
54,807
-1,347
| -2% | -$34.1K |
|
8
Tower Semiconductor
TSEM
$26.4B
| $1.23M | 3.98% |
64,036
-4,993
| -7% | -$93.2K |
|
|
9
NexGen Energy
NXE
$6.05B
| $1.13M | 3.66% |
871,732
-294,775
| -25% | -$406K |
|
10
Corcept Therapeutics
CORT
$10.2B
| $1.05M | 3.38% |
74,139
-2,685
| -3% | -$33K |
|
11
Honeywell
HON
$77B
| $960K | 3.1% |
6,020
-174
| -3% | -$27.7K |
|
12
Alaska Air
ALK
$5.15B
| $959K | 3.1% |
14,776
-508
| -3% | -$32K |
|
13
BeyondSpring
BYSI
$46.1M
| $853K | 2.75% |
47,138
-1,090
| -2% | -$19.5K |
|
14
Onto Innovation
ONTO
$13.6B
| $838K | 2.71% |
25,685
-1,146
| -4% | -$35.7K |
|
15
Amazon
AMZN
$2.5T
| $783K | 2.53% |
9,020
-180
| -2% | -$16.7K |
|
|
PARAA
16
DELISTED
Paramount Global Class A
PARAA
| $692K | 2.23% |
17,150
-515
| -3% | -$24.8K |
|
|
SF
17
Stifel
SF
$12.3B
| $605K | 1.95% |
23,708
| – | – |
|
18
JetBlue
JBLU
$1.96B
| $553K | 1.79% |
32,990
-1,122
| -3% | -$20.4K |
|
19
Tesla
TSLA
$1.24T
| $462K | 1.49% |
28,770
-930
| -3% | -$14.6K |
|
20
PepsiCo
PEP
$186B
| $444K | 1.43% |
3,237
-204
| -6% | -$27.1K |
|
21
Alphabet (Google) Class C
GOOG
$3.9T
| $429K | 1.39% |
7,040
| – | – |
|
|
22
Philip Morris
PM
$301B
| $421K | 1.36% |
5,546
+178
| +3% | +$14.1K |
|
23
Netflix
NFLX
$292B
| $290K | 0.94% |
10,850
| – | – |
|
24
Applied Materials
AMAT
$426B
| $243K | 0.78% |
4,868
-210
| -4% | -$10.1K |
|
25
JPMorgan Chase
JPM
$939B
| $228K | 0.74% |
1,937
-54
| -3% | -$6.11K |
|
Similar funds
GC
GCS
NI
CMANY
GMC
JCM
PCA
ACM
Tanaka Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Tanaka Capital Management held 50 positions worth $31M, down 5.1% from $32.6M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Tanaka Capital Management withdrew a net $2.64M in Q3 2019, closing 1 position and reducing 29 holdings. Its most notable exit was Neurotrope, Inc. Common, an estimated $1.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Materials.
Against the trend, Tanaka Capital Management added an estimated $308K to Catalyst Pharmaceutical.
- Tanaka Capital Management added most to Catalyst Pharmaceutical in Q3 2019, an estimated $308K increase.
- Tanaka Capital Management's biggest Q3 2019 reduction was NexGen Energy, cutting an estimated $406K.
- Tanaka Capital Management fully exited Neurotrope, Inc. Common in Q3 2019, selling an estimated $1.52M.
- Tanaka Capital Management's ten largest holdings make up 64% of its $31M portfolio in Q3 2019.
- Tanaka Capital Management opened 0 new positions and closed 1 in Q3 2019.
- Tanaka Capital Management's portfolio value fell 5.1% quarter-over-quarter to $31M.
Based on Tanaka Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.